"Results indicate that vanillin a selective agonist of TRPV1 and donepezil a potent acetylcholine esterase inhibitor have attenuated intracerebroventricular streptozotocin and AlCl3+d-galactose induced experimental Alzheimer's disease. Hence pharmacological positive modulation of TRPV1 channels may be a potential research target for mitigation of Alzheimer's disease."xsd:string